Literature DB >> 24231471

Good riddance to dopamine: roles for the dopamine transporter in synaptic function and dopamine-associated brain disorders.

Raajaram Gowrishankar1, Maureen K Hahn2, Randy D Blakely3.   

Abstract

The neurotransmitter dopamine (DA) plays a critical role in CNS circuits that provide for attention, executive function, reward responses, motivation and movement. DA is inactivated by the cocaine- and amphetamine-sensitive DA transporter (DAT), a protein that also provides a pathway for non-vesicular DA release. After a brief review of DAT function and psychostimulant actions, we consider the importance DAT in relation to the distinct firing patterns of DA neurons that permit awareness of novelty and reward. Finally, we review recent efforts to gather direct support for DAT-linked disorders, with a specific focus on DAT mutations recently identified in subjects with ADHD.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ADHD; Amphetamine; Dopamine; Genetics; Transporter

Mesh:

Substances:

Year:  2013        PMID: 24231471     DOI: 10.1016/j.neuint.2013.10.016

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  25 in total

Review 1.  Neurobehavioral changes arising from early life dopamine signaling perturbations.

Authors:  Lorena B Areal; Randy D Blakely
Journal:  Neurochem Int       Date:  2020-04-20       Impact factor: 3.921

2.  Atypical dopamine efflux caused by 3,4-methylenedioxypyrovalerone (MDPV) via the human dopamine transporter.

Authors:  Aparna Shekar; Jenny I Aguilar; Greta Galli; Nicholas V Cozzi; Simon D Brandt; Arnold E Ruoho; Michael H Baumann; Heinrich J G Matthies; Aurelio Galli
Journal:  J Chem Neuroanat       Date:  2017-02-03       Impact factor: 3.052

3.  Hybrid dopamine uptake blocker-serotonin releaser ligands: a new twist on transporter-focused therapeutics.

Authors:  Bruce E Blough; Antonio Landavazo; John S Partilla; Michael H Baumann; Ann M Decker; Kevin M Page; Richard B Rothman
Journal:  ACS Med Chem Lett       Date:  2014-04-15       Impact factor: 4.345

Review 4.  Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder.

Authors:  Marc A Mergy; Raajaram Gowrishankar; Gwynne L Davis; Tammy N Jessen; Jane Wright; Gregg D Stanwood; Maureen K Hahn; Randy D Blakely
Journal:  Neurochem Int       Date:  2013-12-08       Impact factor: 3.921

Review 5.  A Comprehensive View of the Neurotoxicity Mechanisms of Cocaine and Ethanol.

Authors:  Renato B Pereira; Paula B Andrade; Patrícia Valentão
Journal:  Neurotox Res       Date:  2015-06-24       Impact factor: 3.911

6.  The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulants.

Authors:  Marc A Mergy; Raajaram Gowrishankar; Paul J Gresch; Stephanie C Gantz; John Williams; Gwynne L Davis; C Austin Wheeler; Gregg D Stanwood; Maureen K Hahn; Randy D Blakely
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-20       Impact factor: 11.205

7.  Reciprocal Phosphorylation and Palmitoylation Control Dopamine Transporter Kinetics.

Authors:  Amy E Moritz; Danielle E Rastedt; Daniel J Stanislowski; Madhur Shetty; Margaret A Smith; Roxanne A Vaughan; James D Foster
Journal:  J Biol Chem       Date:  2015-09-30       Impact factor: 5.157

8.  Dopamine Transporter Localization in Medial Forebrain Bundle Axons Indicates Its Long-Range Transport Primarily by Membrane Diffusion with a Limited Contribution of Vesicular Traffic on Retromer-Positive Compartments.

Authors:  Tarique R Bagalkot; Ethan R Block; Kristen Bucchin; Judith Joyce Balcita-Pedicino; Michael Calderon; Susan R Sesack; Alexander Sorkin
Journal:  J Neurosci       Date:  2020-11-24       Impact factor: 6.167

9.  Region-Specific Regulation of Presynaptic Dopamine Homeostasis by D2 Autoreceptors Shapes the In Vivo Impact of the Neuropsychiatric Disease-Associated DAT Variant Val559.

Authors:  Raajaram Gowrishankar; Paul J Gresch; Gwynne L Davis; Rania M Katamish; Justin R Riele; Adele M Stewart; Roxanne A Vaughan; Maureen K Hahn; Randy D Blakely
Journal:  J Neurosci       Date:  2018-05-08       Impact factor: 6.167

Review 10.  Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.

Authors:  Kelly M Lohr; Shababa T Masoud; Ali Salahpour; Gary W Miller
Journal:  Eur J Neurosci       Date:  2016-09-02       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.